Get the latest Science News and Discoveries
Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression
Interleukin-33 (IL-33) is a master initiator of cancer-prone chronic inflammation. Here, the authors show that TLR3/4-TBK1-IRF3 pathway activation induces IL-33, and the cholesterol-lowering drug, statin, blocks this pathway to suppress chronic inflammation and its cancer sequela.
None
Or read this on r/EverythingScience